Research ArticleALLERGY

Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis

See allHide authors and affiliations

Science Translational Medicine  23 Oct 2019:
Vol. 11, Issue 515, eaax2945
DOI: 10.1126/scitranslmed.aax2945

Article Information

vol. 11 no. 515

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication March 12, 2019
  • Resubmitted June 15, 2019
  • Accepted for publication September 25, 2019
  • .

Author Information

  1. Yi-Ling Chen1,
  2. Danuta Gutowska-Owsiak1,2,
  3. Clare S. Hardman1,
  4. Melanie Westmoreland3,
  5. Teena MacKenzie3,
  6. Liliana Cifuentes3,
  7. Dominic Waithe1,
  8. Antonia Lloyd-Lavery3,
  9. Allison Marquette4,
  10. Marco Londei4 and
  11. Graham Ogg1,3,*
  1. 1MRC Human Immunology Unit, NIHR Biomedical Research Centre, Radcliffe Department of Medicine, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK.
  2. 2Institute of Biotechnology UG, Intercollegiate Faculty of Biotechnology of University of Gdańsk and Medical University of Gdańsk, 80-307 Gdańsk, Poland.
  3. 3Oxford University Hospitals, Oxford OX3 7LE, UK.
  4. 4AnaptysBio Inc., San Diego, CA 92121, USA.
  1. *Corresponding author. Email: graham.ogg{at}ndm.ox.ac.uk

Altmetric

Article usage

Article usage: October 2019 to December 2019

AbstractFullPdf
Oct 201959921152571
Nov 20191292301237
Dec 20192052217